Suppr超能文献

简单、联合血脂标志物与2型糖尿病20年累积发病率之间的关联:阿提卡队列研究(2002 - 2022年)

Association between simple, combined lipid markers and 20-year cumulative incidence of type 2 diabetes: the ATTICA cohort study (2002-2022).

作者信息

Kechagia Ioanna, Barkas Fotios, Liberopoulos Evangelos, Chrysohoou Christina, Sfikakis Petros P, Tsioufis Costas, Pitsavos Christos, Panagiotakos Demosthenes

机构信息

Department of Nutrition and Dietetics, School of Health Sciences & Education, Harokopio University, Athens, 17676, Greece.

Department of Clinical Dietetics-Nutrition, HYGEIA Hospital, Athens, 15123, Greece.

出版信息

Lipids Health Dis. 2024 Dec 20;23(1):413. doi: 10.1186/s12944-024-02383-8.

Abstract

BACKGROUND

The aim of this study was to evaluate the association between simple, combined lipid biomarkers, and 20-year cumulative incidence of new type 2 diabetes mellitus (T2DM) among adults participating in the ATTICA cohort study (2002-2022).

METHODS

The present analysis included data from 2000 individuals free of T2DM at baseline (age 43 ± 13 years; 51% women). Sociodemographic, anthropometric, lifestyle, clinical, and biochemical parameters were collected at baseline and follow-up examinations; combined lipid markers were evaluated.

RESULTS

The 20-year cumulative incidence of T2DM was 26.3% (95%CI 24.4, 28.3%). All, simple and combined lipid markers were independently associated with new T2DM onset. The accuracy of simple and combined markers was approximately 75%, without any significant differences between simple and combined indices. The additive correct classification gain of lipid markers to glucose metabolism indices on 20-year new T2DM cumulative incidence varied between 0.9% for cardiometabolic index to 10.6% for LDL-cholesterol.

CONCLUSIONS

Lipid profile is associated with the long-term onset of T2DM. Evaluated through simple or combined markers, lipid profiles can be utilized for identifying and improving risk stratification in individuals at high risk for T2DM, while also enhancing the effectiveness of primary prevention measures and public health strategies.

摘要

背景

本研究旨在评估参与阿提卡队列研究(2002 - 2022年)的成年人中,简单和联合脂质生物标志物与2型糖尿病(T2DM)20年累积发病率之间的关联。

方法

本分析纳入了2000名基线时无T2DM的个体的数据(年龄43±13岁;51%为女性)。在基线和随访检查时收集社会人口统计学、人体测量学、生活方式、临床和生化参数;评估联合脂质标志物。

结果

T2DM的20年累积发病率为26.3%(95%CI 24.4, 28.3%)。所有简单和联合脂质标志物均与新发T2DM独立相关。简单和联合标志物的准确性约为75%,简单指标和联合指标之间无显著差异。脂质标志物对20年新发T2DM累积发病率的葡萄糖代谢指标的附加正确分类增益在心脏代谢指数的0.9%至低密度脂蛋白胆固醇的10.6%之间变化。

结论

血脂谱与T2DM的长期发病有关。通过简单或联合标志物评估,血脂谱可用于识别和改善T2DM高危个体的风险分层,同时还可提高一级预防措施和公共卫生策略的有效性。

相似文献

本文引用的文献

5
Treat Obesity to Treat Type 2 Diabetes Mellitus.治疗肥胖以治疗2型糖尿病。
Diabetes Ther. 2024 Mar;15(3):611-622. doi: 10.1007/s13300-024-01536-3. Epub 2024 Feb 4.
7
Obesity and Dyslipidemia: A Review of Current Evidence.肥胖与血脂异常:当前证据综述。
Curr Obes Rep. 2023 Sep;12(3):207-222. doi: 10.1007/s13679-023-00518-z. Epub 2023 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验